Monitored Access

Doses in secure cartridges that can only be dispensed when paired with a SmartKey

Prescription Guidance

A comprehensive system that provides riminders and guidance

Data Generation

SmartKey logs activity, prompts for testing and input of symptom status, and syncs with cloud-based servers to communicate usage details in real time

Insight

Lab tests paired with dose timestamp data produce unprecendented insight into treatment progress

BunaTrack:
Secure Buprenorphine-Naloxone

Secure Buprenorphine-Naloxone Cartridges

and a Very Smart Key

Advancing treatment for opioid use disorder: Buprenorphine-naloxone pre-packaged in tamper-evident cartridges and dispensed via a SmartKey device that authenticates patients, tracks and controls dose access, and creates actionable data.

Well reviewed and received by prescribers

Drug Access Control and Tracking

Cartridges are locked at all times to deter unauthorized access and the dispensation of each dose is controlled and time-stamped

Detailed Reports for Clinicians

Data from the SmartKey and other sources enables actionable reports and improved Risk Evaluation and Mitigation (REMS)

Improved Patient Management

Detailed reports identify gaps, allowing for patient portfolio review and early risk detection

Information Interface for Patients

Our system includes an app to better guide and coach the patient through the prescribed treatment while also collecting symptom data

The Competition

Medications are still primarily delivered in containers that lack usage tracking, access control, treatment guidance interfaces, or connection to decision support systems.

Our solutions

Addressing Opioid Use Disorder

People misusing opioids annually

0.0m

Patients in OUD treatments

0.0m

Patients in OUD treatments

0.0m

Patients in OUD treatments

Compliance rate

$0K

Per patient yearly cost if uncontrolled

$0K

Per patient yearly cost if uncontrolled

$0K

Per patient yearly cost if uncontrolled

More than 100 Americans die every day from an opioid overdose. The misuse of opioids including prescription pain relievers, heroin, and synthetic opiois such as fentanyl is a serious national crisis that affects public health as well as social and economic welfare.

The Centers for Disease Control and Prevention estimates that the total "economic burden" of prescription opioid misuse along in the United States is $78.5 billion a year, including the costs of healthcare, lost productivity, addiction treatment, and criminal justice involvement.

Our solutions

Addressing Prescriber Concerns

Surveyed buprenorphine prescribers (N>30) indicate they would use Bunatrack with roughly 50% of their patients

Feature/benefit

Average Prescriber Interest (max=5)

Improvement in medication compliance

4.36

Detection of unauthorized access

4.18

Deterrence of access by child and juvenile non-patients

4.60

Representative average

27,888 Patient-days

72%

Representative average

27,888 Patient-days

72%

Representative average

27,888 Patient-days

72%

Representative average

27,888 Patient-days

72%

Representative average

27,888 Patient-days

72%

BunaTrack

2000+ Patient-Days

97%

BunaTrack

2000+ Patient-Days

97%

BunaTrack

2000+ Patient-Days

97%

BunaTrack

2000+ Patient-Days

97%

BunaTrack

2000+ Patient-Days

97%

Higher Compliance Rate

BunaTrack patients took medication as prescribed 97% of days (CI94% to 100%), versus rederence TAU rate of 72% (CI 68% to 76%).

97% Medication Compliance

6.8/7 Satisfaction Rating

97% Medication Compliance

6.8/7 Satisfaction Rating

In Development

Follow-on Opportunity: Improve Pain Management

130 million

opioid prescriptions written per year

130 million

opioid prescriptions written per year

60 million

Americans suffer from chronic pain

60 million

Americans suffer from chronic pain

40%

of patients are "High-Risk"

High Risk

40%

of patients are "High-Risk"

High Risk

130 million

opioid prescriptions written per year

130 million

opioid prescriptions written per year

60 million

Americans suffer from chronic pain

60 million

Americans suffer from chronic pain

40%

of patients are "high-Risk"

High Risk

40%

of patients are "high-Risk"

High Risk

130 million

opioid prescriptions written per year

60 million

Americans suffer from chronic pain

40%

of patients are "high-Risk"

High Risk

Unmet Need: Controlled Pain Management for high-risk populations (risk factors include smoking, alcoholism, mood disorder, anxiety).

Product Goal: Guide patients off of opioids within 90 days.

Stay informed.

Updates on new therapies.

Our solutions

Addressing Prescriber Concerns

Surveyed buprenorphine prescribers (N>30) indicate they would use Bunatrack with roughly 50% of their patients

Feature/benefit

Average Prescriber Interest (max=5)

Improvement in medication compliance

4.36

Improvement in medication compliance

4.36

Detection of unauthorized access

4.18

Detection of unauthorized access

4.18

Deterrence of access by child and juvenile non-patients

4.60

Deterrence of access by child and juvenile non-patients

4.60

Our Solutions

Addressing Prescriber Concerns

Surveyed buprenorphine prescribers (N>30) indicate they would use Bunatrack with roughly 50% of their patients

Feature/benefit

Average Prescriber Interest (max=5)

Improvement in medication compliance

4.36

Improvement in medication compliance

4.36

Detection of unauthorized access

4.18

Detection of unauthorized access

4.18

Deterrence of access by child and juvenile non-patients

4.60

Deterrence of access by child and juvenile non-patients

4.60

BunaTrack:Secure Buprenorphine-Naloxone

BunaTrack:Secure Buprenorphine-Naloxone

Secure Buprenorphine-Naloxone Cartridges

and a Very Smart Key

and a Very Smart Key

and a Very Smart Key

Well reviewed and received by prescribers

Well reviewed and received by prescribers

Our solutions

Our solutions

Our solutions

Addressing Opioid Use Disorder

People misusing opioids annually

People misusing opioids annually

People misusing opioids annually

Patients in OUD treatments

Patients in OUD treatments

Patients in OUD treatments

Compliance rate

Compliance rate

Compliance rate

Per patient yearly cost if uncontrolled

Per patient yearly cost if uncontrolled

Per patient yearly cost if uncontrolled

Our solutions

In Development

In Development

In Development

Follow-on Opportunity: Improve Pain Management

Unmet Need: Controlled Pain Management for high-risk populations (risk factors include smoking, alcoholism, mood disorder, anxiety).

Unmet Need: Controlled Pain Management for high-risk populations (risk factors include smoking, alcoholism, mood disorder, anxiety).

Product Goal: Guide patients off of opioids within 90 days.

Stay informed.

Stay informed.

Updates on new therapies.

Updates on new therapies.

Our solutions

Our solutions

Our Solutions

Our Solutions

Addressing Prescriber Concerns

BunaTrack:
Secure Buprenorphine-Naloxone

BunaTrack:
Secure Buprenorphine-Naloxone